BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36533978)

  • 1. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study.
    Casadepax-Soulet C; Benali K; Crestani B; Piekarski E; Mahida B; Ebstein E; Juge PA; Forien M; Dieudé P; Ottaviani S
    Clin Exp Rheumatol; 2023 Jul; 41(7):1456-1462. PubMed ID: 36533978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Allard B; Devauchelle-Pensec V; Saraux A; Nowak E; Tison A; Boukhlal S; Guellec D; Jousse-Joulin S; Cornec D; Marhadour T; Le Pennec R; Salaün PY; Querellou S
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1297-1309. PubMed ID: 38095675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis.
    van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Jamar F; Slart RHJA; Gheysens O
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1876-1889. PubMed ID: 33372248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of 18F-FDG-PET/CT in detecting musculoskeletal and vascular involvement in patients with polymyalgia rheumatica receiving glucocorticoids.
    Serrano-Combarro A; Prieto-Peña D; Martínez-Rodríguez I; Martínez-Amador N; Loricera J; Blanco R
    Eur J Intern Med; 2024 Jun; 124():78-83. PubMed ID: 38302404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study.
    Sondag M; Guillot X; Verhoeven F; Blagosklonov O; Prati C; Boulahdour H; Wendling D
    Rheumatology (Oxford); 2016 Aug; 55(8):1452-7. PubMed ID: 27107429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?
    Wakura D; Kotani T; Takeuchi T; Komori T; Yoshida S; Makino S; Hanafusa T
    PLoS One; 2016; 11(7):e0158509. PubMed ID: 27384410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin.
    Iannuzzi F; Hysa E; Camellino D; Morbelli S; Bauckneht M; Sambuceti G; Cutolo M; Cimmino MA
    Clin Exp Rheumatol; 2023 Apr; 41(4):812-820. PubMed ID: 37073635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression tree analysis.
    Ikuma D; Sawa N; Yamanouchi M; Oba Y; Mizuno H; Suwabe T; Hoshino J; Ubara Y
    Mod Rheumatol; 2024 Mar; 34(3):474-478. PubMed ID: 37279960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of
    Pean de Ponfilly-Sotier M; Besson FL; Gomez L; Ottaviani S; Dieudé P; Pavy S; Mariette X; Seror R; Nocturne G
    Joint Bone Spine; 2022 May; 89(3):105325. PubMed ID: 34915108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.
    Yamashita H; Kubota K; Takahashi Y; Minaminoto R; Morooka M; Ito K; Kano T; Kaneko H; Takashima H; Mimoiri A
    Mod Rheumatol; 2012 Sep; 22(5):705-11. PubMed ID: 22205118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica.
    van der Geest KSM; van Sleen Y; Nienhuis P; Sandovici M; Westerdijk N; Glaudemans AWJM; Brouwer E; Slart RHJA
    Rheumatology (Oxford); 2022 Mar; 61(3):1072-1082. PubMed ID: 34117743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity.
    Owen CE; Poon AMT; Yang V; McMaster C; Lee ST; Liew DFL; Leung JL; Scott AM; Buchanan RRC
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2461-2468. PubMed ID: 32090280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
    Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymyalgia rheumatica in 18-fluorodeoxyglucose-positron-emission-tomography/computed tomography : Improvement in diagnostic accuracy and differentiation from rheumatoid arthritis].
    Witte F; Lakomek HJ; Holzinger J; Reinbold WD
    Z Rheumatol; 2023 Mar; 82(2):91-101. PubMed ID: 34851442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica.
    Owen CE; Poon AMT; Lee ST; Yap LP; Zwar RB; McMenamin CM; Lam SKL; Liew DFL; Pathmaraj K; Kemp A; Scott AM; Buchanan RRC
    Rheumatology (Oxford); 2018 Feb; 57(2):345-353. PubMed ID: 29121248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell Arteritis.
    Heras-Recuero E; Martínez de Bourio-Allona M; Landaeta-Kancev LC; Blázquez-Sánchez T; Torres-Roselló A; Álvarez-Rubio M; Belhaj-Gandar M; Martínez-López JA; Martínez-Dhier L; Llorca J; Largo R; González-Gay MÁ
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of positive
    Prieto-Peña D; Martínez-Rodríguez I; Loricera J; Banzo I; Calderón-Goercke M; Calvo-Río V; González-Vela C; Corrales A; Castañeda S; Blanco R; Hernández JL; González-Gay MÁ
    Semin Arthritis Rheum; 2019 Feb; 48(4):720-727. PubMed ID: 29903537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica.
    Rehak Z; Vasina J; Nemec P; Fojtik Z; Koukalova R; Bortlicek Z; Rehakova D; Adam J; Vavrusova A; Adam Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):629-36. PubMed ID: 26006092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica.
    Camellino D; Paparo F; Morbelli SD; Pesce G; Bauckneht M; Bagnasco M; Cutolo M; Sambuceti G; Cimmino MA
    Clin Exp Rheumatol; 2022 Jan; 40(1):78-85. PubMed ID: 33822711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of
    Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM
    J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.